DETECT‐AD (Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer’s Disease): Baseline results of a simulated anti‐amyloid clinical trial using digital biomarkers

Abstract

Background: Current conventional cognitive testing and self‐report questionnaires used in clinical trials for Alzheimer’s disease (AD) especially in prodromal early stages are poorly sensitive to detect subtle and gradual clinical change as well as lack ecological validity.